In Bangladesh, where healthcare resources are limited, incorporating fecal lactoferrin testing into routine clinical practice could aid in early and accurate differentiation of IBD from IBS, reducing unnecessary endoscopic procedures and improving patient management. The gene discussed is LTF; the disease is inflammatory bowel disease.